Julie C. Holder

6.6k citations

32 papers · 3.3k indexed · 1 hit paper · h-index 23

Molecular Biology top 5%
Physiology top 5%
Epidemiology top 5%
Surgery top 10%
Cancer Research top 10%

Co-authors: Gregory Murphy Stephen A. Smith Darren A.E. Cross David Haigh Neil Pearce Stacey L. Corcoran John Yates Matthew P. Coghlan
Topics: Peroxisome Proliferator-Activated Receptors (11 papers)Metabolism, Diabetes, and Cancer (7 papers)Adipose Tissue and Metabolism (6 papers)
Cited by: Molecular Biology Physiology Biochemistry
Journals: Journal of Clinical Investigation PLoS ONE Diabetes
Partner nations: United Kingdom United States Australia

In The Last Decade

Julie C. Holder

32 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

2000 771 citations Matthew P. Coghlan, Ainsley A. Culbert et al. Chemistry & Biology profile →

Peers

Countries citing papers authored by Julie C. Holder

Since Specialization

Citations

This map shows the geographic impact of Julie C. Holder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie C. Holder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie C. Holder more than expected).

Fields of papers citing papers by Julie C. Holder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie C. Holder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie C. Holder. The network helps show where Julie C. Holder may publish in the future.

Co-authorship network of co-authors of Julie C. Holder

This figure shows the co-authorship network connecting the top 25 collaborators of Julie C. Holder. A scholar is included among the top collaborators of Julie C. Holder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie C. Holder. Julie C. Holder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GT005, a gene therapy for the treatment of dry age-related macular degeneration (AMD) 2020 ·Investigative Ophthalmology & Visual Science ·Scott Ellis,(unknown),Julie C. Holder,Elise Orhan,(unknown)	19
2	Discovery of a novel 2,3,11,11a-tetrahydro-1H-pyrazino[1,2-b]isoquinoline-1,4(6H)-dione series promoting neurogenesis of human neural progenitor cells 2015 ·Bioorganic & Medicinal Chemistry Letters ·Hong Lin,Haiyan Fang,Jamie Wang,(unknown),(unknown),(unknown),Jie Luo,(unknown),Libo Chen,Douglas J. Minick,Ken Arai,Emiri T. Mandeville,Eng H. Lo,Julie C. Holder,Tsu Tshen Chuang,Jing Zhao	10
3	Differential Effects of Isoxazole-9 on Neural Stem/Progenitor Cells, Oligodendrocyte Precursor Cells, and Endothelial Progenitor Cells 2015 ·PLoS ONE ·Seong‐Ho Koh,Anna C. Liang,Yōko Takahashi,Takakuni Maki,Akihiro Shindo,Noriko Osumi,Jing Zhao,Hong Lin,Julie C. Holder,Tsu Tshen Chuang,John D. McNeish,Ken Arai,Eng H. Lo	14
4	Differentiation-Associated Reprogramming of the Transforming Growth Factor β Receptor Pathway Establishes the Circuitry for Epithelial Autocrine/Paracrine Repair 2012 ·PLoS ONE ·(unknown),(unknown),Claire L. Varley,Lisa A. Kirkwood,Angela White,Julie C. Holder,Ludwik K. Trejdosiewicz,Jennifer Southgate	6
5	Intestinal Detoxification Limits the Activation of Hepatic Pregnane X Receptor by Lithocholic Acid 2009 ·Drug Metabolism and Disposition ·Bryn M. Owen,Alexandra Milona,Saskia W. C. van Mil,Peter Clements,Julie C. Holder,Mohamed Boudjelal,William Cairns,Malcolm G. Parker,Roger White,Catherine Williamson	24
6	FOXA1 and IRF-1 intermediary transcriptional regulators of PPARγ-induced urothelial cytodifferentiation 2008 ·Cell Death and Differentiation ·Claire L. Varley,(unknown),Julie C. Holder,Jennifer Southgate	57
7	Sensitivity of Normal, Paramalignant, and Malignant Human Urothelial Cells to Inhibitors of the Epidermal Growth Factor Receptor Signaling Pathway 2008 ·Molecular Cancer Research ·Nicola J. MacLaine,(unknown),Julie C. Holder,Robert W. Rees,Jennifer Southgate	27
8	Glycogen Synthase Kinase-3 Mediates Acetaminophen-Induced Apoptosis in Human Hepatoma Cells 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Patricia Macanas-Pirard,(unknown),(unknown),Julie C. Holder,Richard H. Hinton,George E.N. Kass	34
9	Towards the creation of an international toxicology information centre 2005 ·Toxicology ·Philip N. Judson,Paul Cooke,Nancy G. Doerrer,Nigel Greene,Robert P. Hanzlik,Christopher R. Hardy,Andreas Hartmann,(unknown),Julie C. Holder,Lutz Müller,Thomas Steger‐Hartmann,Andreas Rothfuß,Mark Smith,Karluss Thomas,Jonathan D. Vessey,Errol Zeiger	37
10	Peroxisome Proliferator-Activated Receptor (PPAR)-β/δ Stimulates Differentiation and Lipid Accumulation in Keratinocytes 2004 ·Journal of Investigative Dermatology ·Matthias Schmuth,Christopher M. Haqq,William Cairns,Julie C. Holder,Sheri T. Dorsam,Sandra Chang,(unknown),Ashley J. Fowler,Gary S. Chuang,Arthur H. Moser,Barbara E. Brown,Mao‐Qiang Man,Yoshikazu Uchida,Kristina Schoonjans,Johan Auwerx,Pierre Chambon,Timothy M. Willson,Peter M. Elias,Kenneth R. Feingold	195
11	Tryptophan?NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation 2004 ·Archives of Toxicology ·Jane Delaney,Mark P. Hodson,Hansa Thakkar,Susan C. Connor,Brian C. Sweatman,(unknown),Paul McGill,Julie C. Holder,(unknown),John N. Haselden,Catherine J. Waterfield	40
12	Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter 2004 ·Metabolism ·Neil Pearce,Jonathan R.S. Arch,John C. Clapham,Matthew P. Coghlan,Stacey L. Corcoran,Carolyn A. Lister,Andrea Llano,Gary B.T. Moore,Gregory Murphy,Stephen A. Smith,(unknown),John Yates,Alastair Morrison,Alexander James Harper,(unknown),Alejandro Abuin,Edward T. Wargent,Julie C. Holder	90
13	Differential Regulation of Adipocytokine mRNAs by Rosiglitazone in db/db Mice 2001 ·Biochemical and Biophysical Research Communications ·Gary B.T. Moore,Helen Chapman,Julie C. Holder,Carolyn A. Lister,Valerie Piercy,Stephen A. Smith,John C. Clapham	125
14	PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer 2000 ·Trends in Pharmacological Sciences ·Gregory Murphy,Julie C. Holder	318
15	Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcriptionbreakdown → 2000 ·Chemistry & Biology ·Matthew P. Coghlan,Ainsley A. Culbert,Darren A.E. Cross,Stacey L. Corcoran,John Yates,Neil Pearce,Oliver Rausch,Gregory Murphy,Paul S. Carter,(unknown),David Mills,Murray J. B. Brown,David Haigh,Robert W. Ward,David G. Smith,Kenneth Murray,Alastair D. Reith,Julie C. Holder	771
16	Non-thiazolidinedione antihyperglycaemic agents. Part 3: the effects of stereochemistry on the potency of α-methoxy-β-phenylpropanoic acids 1999 ·Bioorganic & Medicinal Chemistry ·David Haigh,(unknown),Helen Birrell,Derek R. Buckle,Barrie C. C. Cantello,Drake S. Eggleston,R. Curtis Haltiwanger,Julie C. Holder,Carolyn A. Lister,Ivan L. Pinto,Harshad K. Rami,John T. Sime,Stephen A. Smith,(unknown)	30
17	Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γ 1998 ·Journal of Pharmacology and Experimental Therapeutics ·Paul Young,Derek R. Buckle,Barrie C. C. Cantello,Helen Chapman,John C. Clapham,Paul J. Coyle,David Haigh,Richard M. Hindley,Julie C. Holder,(unknown),(unknown),K. W. M. Lawrie,Danuta E. Mossakowska,Gregory Murphy,(unknown),Stephen A. Smith	90
18	Insulin activates protein kinase B, inhibits glycogen synthase kinase‐3 and activates glycogen synthase by rapamycin‐insensitive pathways in skeletal muscle and adipose tissue 1997 ·FEBS Letters ·Darren A.E. Cross,Peter Watt,Morag Shaw,Jeroen van der Kaay,C. Peter Downes,Julie C. Holder,Philip P. Cohen	181
19	Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling 1995 ·Diabetes ·(unknown),Michael A. Cawthorne,(unknown),Julie C. Holder,(unknown),(unknown),(unknown),Carolyn A. Lister,Stephen A. Smith	34
20	An unusual fructose 1,6-bisphosphate-activated lactate dehydrogenase from the ascidian Pyura stolonifera 1995 ·Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology ·Sue Brennan,Julie C. Holder,John J. Baldwin	2

About Julie C. Holder

Julie C. Holder is a scholar working on Developmental Neuroscience, Clinical Biochemistry and Toxicology, having authored 32 papers that have together received 3.3k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (11 papers), Metabolism, Diabetes, and Cancer (7 papers) and Adipose Tissue and Metabolism (6 papers). The work is most often cited by research in Molecular Biology (2.3k citations), Physiology (761 citations) and Biochemistry (198 citations). Julie C. Holder has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Gregory Murphy, Stephen A. Smith, Darren A.E. Cross, David Haigh, Neil Pearce, Stacey L. Corcoran, John Yates, Matthew P. Coghlan, Oliver Rausch and Carolyn A. Lister. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact